You are being directed away from the Fresenius Medical Care Australia website to an external website where we are not responsible for the information displayed on such sites. We note that such information may not comply with Australian regulatory requirements.
Fresenius Medical Care’s product portfolio for Acute Kidney Injury supports treatment of your acute patients. As part of our commitment to ensuring optimal outcomes for all patients with AKI, we are now proud to offer Continuous Renal Replacement Therapies (CRRT) and Extended Daily Diafiltration (EDD-f).
multiFiltrate Ci-Ca® offers Regional Citrate Anticoagulation Therapies.
Advantages of citrate anticoagulation:
As the world’s largest integrated provider of dialysis products and services , Fresenius Medical Care has introduced the 5008/6008 therapy system and all its individual components to ICUs in Australia and New Zealand facilities.
Key features include: